Clinical trial reportClinical and experimental dermatologyPublished
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Clinical and experimental dermatology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Ichthyosis; Ichthyosiform Erythroderma, Congenital; Ichthyosis, Lamellar; Ichthyosis, X-Linked; Isotretinoin; Immunoglobulin A; Adult
- PubMed ID
- 36794376
- Added to directory
- Source checked